A detailed history of Tobam transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tobam holds 75,647 shares of EW stock, worth $5.66 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
75,647
Previous 2,648 2756.76%
Holding current value
$5.66 Million
Previous $245,000 1937.55%
% of portfolio
0.91%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$59.7 - $93.78 $4.36 Million - $6.85 Million
72,999 Added 2756.76%
75,647 $4.99 Million
Q2 2024

Jul 29, 2024

SELL
$84.3 - $94.31 $129,484 - $144,860
-1,536 Reduced 36.71%
2,648 $245,000
Q1 2024

May 02, 2024

BUY
$72.54 - $95.56 $80,374 - $105,880
1,108 Added 36.02%
4,184 $400,000
Q4 2023

Jan 26, 2024

SELL
$61.71 - $77.76 $75,471 - $95,100
-1,223 Reduced 28.45%
3,076 $235,000
Q3 2023

Oct 31, 2023

SELL
$69.28 - $93.38 $38,173 - $51,452
-551 Reduced 11.36%
4,299 $298,000
Q2 2023

Jul 31, 2023

SELL
$81.41 - $94.33 $123,091 - $142,626
-1,512 Reduced 23.77%
4,850 $458,000
Q1 2023

May 03, 2023

BUY
$74.26 - $84.51 $48,046 - $54,677
647 Added 11.32%
6,362 $526,000
Q4 2022

Feb 02, 2023

BUY
$68.3 - $87.44 $203,465 - $260,483
2,979 Added 108.88%
5,715 $426,000
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $28,252 - $36,800
-343 Reduced 11.14%
2,736 $226,000
Q2 2022

Aug 02, 2022

BUY
$86.5 - $128.27 $72,833 - $108,003
842 Added 37.64%
3,079 $293,000
Q1 2022

Apr 25, 2022

BUY
$101.96 - $128.34 $12,337 - $15,529
121 Added 5.72%
2,237 $263,000
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $142,174 - $185,023
2,116 New
2,116 $169,000
Q3 2017

Nov 14, 2017

SELL
$36.29 - $38.83 $98,273 - $105,151
-2,708 Closed
0 $0
Q2 2017

Aug 08, 2017

BUY
N/A
2,708
2,708 $320,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.